The pharmaceutical landscape for diabetes is changing, and transdermal GLP-1 delivery systems represent a promising development. Unlike subcutaneous injections, this technique offers a simpler way to deliver GLP-1 drugs. These transdermal systems slowly release the drug through the epidermis offering a consistent dose of the active agent, which … Read More